These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 7683227

  • 21. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K.
    Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
    [Abstract] [Full Text] [Related]

  • 22. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM, Delwel R, van Buitenen C, Hoogerbrugge H, Löwenberg B.
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [Abstract] [Full Text] [Related]

  • 23. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD.
    Oncol Res; 1994 Mar; 6(2):87-99. PubMed ID: 7949469
    [Abstract] [Full Text] [Related]

  • 24. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 25. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells.
    Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, Huang Y, Ponnathpur V, Mahoney ME.
    Blood; 1993 Nov 15; 82(10):3133-40. PubMed ID: 8219202
    [Abstract] [Full Text] [Related]

  • 26. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA, Groshek P, Griffin JD.
    Leukemia; 1989 May 15; 3(5):328-34. PubMed ID: 2654494
    [Abstract] [Full Text] [Related]

  • 27. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1993 Oct 15; 7(10):1637-44. PubMed ID: 7692194
    [Abstract] [Full Text] [Related]

  • 28. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M.
    Leukemia; 1994 May 15; 8(5):749-57. PubMed ID: 7514244
    [Abstract] [Full Text] [Related]

  • 29. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
    Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1997 Apr 15; 11(4):561-71. PubMed ID: 9096697
    [Abstract] [Full Text] [Related]

  • 30. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB, Minden MD, McCulloch EA.
    Leukemia; 1996 Mar 15; 10(3):410-6. PubMed ID: 8642855
    [Abstract] [Full Text] [Related]

  • 31. Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers.
    Higashigawa M, Kuwabara H, Cao DC, Hori H, Ohkubo T, Kawasaki H, Ido M, Komada Y, Sakurai M.
    Leuk Lymphoma; 1996 Jul 15; 22(3-4):279-85. PubMed ID: 8819077
    [Abstract] [Full Text] [Related]

  • 32. Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine.
    Braess J, Wegendt C, Jahns-Streubel G, Kern W, Keye S, Unterhalt M, Schleyer E, Hiddemann W.
    Br J Haematol; 2000 May 15; 109(2):388-95. PubMed ID: 10848830
    [Abstract] [Full Text] [Related]

  • 33. Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line.
    Handa A, Kashimura T, Kawano N, Yamamoto A, Yoshida S, Jinnai I, Murohashi I, Bessho M, Hirashima K.
    Leukemia; 1997 Apr 15; 11 Suppl 3():387-8. PubMed ID: 9209400
    [Abstract] [Full Text] [Related]

  • 34. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD.
    Leukemia; 1991 May 15; 5(5):386-91. PubMed ID: 1709711
    [Abstract] [Full Text] [Related]

  • 35. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
    Petrucci MT, De Felice L, Ricciardi MR, Ariola C, Mascolo MG, Fenu S, Tafuri A.
    Cytokines Mol Ther; 1996 Dec 15; 2(4):225-30. PubMed ID: 9384708
    [Abstract] [Full Text] [Related]

  • 36. Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells.
    Manome Y, Weichselbaum RR, Kufe DW, Fine HA.
    Oncol Res; 1993 Dec 15; 5(3):139-44. PubMed ID: 8260751
    [Abstract] [Full Text] [Related]

  • 37. GM-CSF and asparaginase potentiate ara-C cytotoxicity in HL-60 cells.
    Powell BL, Wang LM, Gregory BW, Case LD, Kucera GL.
    Leukemia; 1995 Mar 15; 9(3):405-9. PubMed ID: 7885038
    [Abstract] [Full Text] [Related]

  • 38. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D, Yang YC, Clark SC, Kreider BL, Caracciolo D, Rovera G.
    J Immunol; 1987 Nov 15; 139(10):3348-54. PubMed ID: 3500218
    [Abstract] [Full Text] [Related]

  • 39. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, Mahoney ME, Bhalla K.
    Exp Hematol; 1993 Dec 15; 21(13):1640-7. PubMed ID: 8243566
    [Abstract] [Full Text] [Related]

  • 40. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug 15; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.